Pharmaceutical News

RSS

Alimta approved as first treatment for Mesothelioma, a deadly cancer caused by asbestos

Lilly UK announced today that Alimta( (pemetrexed) will be available shortly for the treatment of people diagnosed with mesothelioma, a cancer of the lining of the lungs for which there is no known cure. Pemetrexed is the first licenced treatment for malignant pleural mesothelioma, in combination with cisplatin.

1 Nov 2004

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

The Food and Drug Administration (FDA) has identified about 5 million doses of influenza vaccine from foreign manufacturers; HHS has been able to recoup an additional 300,000 doses of the injectable vaccine originally bought for federal employees and the military; and a major pneumonia vaccine manufacturer plans to triple its production.

29 Oct 2004

New data supporting the use of Renagel in patients who are new to hemodialysis

Genzyme Corporation announced that investigators tomorrow will unveil new preliminary data supporting the use of Renagel (sevelamer hydrochloride) in patients who are new to hemodialysis.

29 Oct 2004

Micro-array technology is revolutionising current drug development

Gene expression micro-array technology is benefiting all phases of the discovery, development and subsequent use of new cancer therapeutics

29 Oct 2004

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

Human Genome Sciences today announced an agreement with GlaxoSmithKline under which GlaxoSmithKline has acquired exclusive worldwide rights to develop and commercialize Albugon (albumin-glucagon-like peptide-1, GLP-1), a drug currently in late-stage preclinical development by Human Genome Sciences for potential use in the treatment of diabetes.

26 Oct 2004

Call for a Senate Inquiry into the pharmacy industry in Australia

With the current Pharmacy Agreement expiring on 30 June 2005 and the current Senate configuration in place until the same date, Dr Glasson said the timing is perfect for a comprehensive review of the protected environment in which the pharmacies operate.

26 Oct 2004

Nonprescription medications to treat upper respiratory infections could save $4.75 billion a year

Using nonprescription, or over-the-counter (OTC), medications to treat common upper respiratory infections could save $4.75 billion a year, according to a new study conducted by researchers from Northwestern University.

26 Oct 2004

New Drug Application for Velac accepted for filing by the FDA

Connetics Corporation, a specialty pharmaceutical company focused on dermatology, today announced that the U.S. Food and Drug Administration has accepted for filing the Company's New Drug Application for Velac

25 Oct 2004

Arizona will receive 22,500 additional doses of flu vaccine

Arizona Governor Janet Napolitano announced today that Arizona will receive 22,500 additional doses of flu vaccine as early as Wednesday, and will distribute the vaccine to local health departments in the next week.

25 Oct 2004

Scientists are testing the effectiveness of a new type of flu vaccine

The experimental vaccine instead relies on a cell line drawn from insects known as silk moths, which are better known for their role as pests attacking crops such as corn, cotton, barley and alfalfa.

25 Oct 2004

Agreement reached on new community pharmacy contract

Patients in the UK will gain a better service from their local pharmacist as Government plans for a more flexible, modernised service moved a step further towards implementation, Health Minister Rosie Winterton announced today.

25 Oct 2004

The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK

The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK. The vaccine, devised by a team led by Dr Helen McShane in Oxford’s Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), is designed to be used in tandem with the tried and tested BCG inoculation – first introduced in 1921 – and not to replace it.

25 Oct 2004

New oral vaccine treatment is effective in reducing Alzheimer's disease pathology

Alzheimer's disease is characterized by progressive loss of cognitive function due to amyloid-beta (Aß) deposits in the central nervous system. If these deposits could be stopped or slowed, Alzheimer's disease might become more manageable.

25 Oct 2004

Fatbuster drug targets obesity

A new drug to combat obesity at a cellular level is in the sights of a University of Queensland scientist.

25 Oct 2004

Call for disclosure of the prices of the most commonly-used prescription drugs over the Internet

In an effort to continue to protect Michigan’s seniors and vulnerable citizens without drug insurance coverage, Attorney General Mike Cox is pushing for disclosure of the prices of the most commonly-used prescription drugs over the Internet to increase consumer awareness and assist buyers with informed choices.

25 Oct 2004

Following the withdrawal of Vioxx, the European Medicines Agency has been asked to review of COX-2 inhibitor medicines

Following the worldwide withdrawal of Vioxx (rofecoxib), the European Medicines Agency (EMEA) has been asked by the European Commission, as a precautionary measure, to conduct a review of COX-2 inhibitor medicines.

25 Oct 2004

Infectious diseases physicians call for financial incentives for industry

In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.

25 Oct 2004

Rosiglitazone helps boost the effectiveness of a treatment for opening clogged arteries

Rosiglitazone, a drug taken to help improve blood sugar levels, also helps boost the effectiveness of a treatment for opening clogged arteries, according to a study in the November issue of Diabetes Care.

25 Oct 2004

Boehringer Ingelheim - New Drug Application (NDA) for tipranavir

The Company is seeking accelerated approval of tipranavir and has requested a priority, six-month review of the NDA. Priority review designation is based upon whether a drug provides a significant improvement in the treatment of a serious or life-threatening disease.

25 Oct 2004

MedImmune bumps up production of FluMist vaccine

MedImmune has announced that it is increasing its planned delivery of FluMist (Influenza Virus Vaccine Live, Intranasal) up to a total of three million doses. Originally the company had completed production of 1.1 million doses.

22 Oct 2004

Pharmaceutical News

Alimta approved as first treatment for Mesothelioma, a deadly cancer caused by asbestos

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

New data supporting the use of Renagel in patients who are new to hemodialysis

Micro-array technology is revolutionising current drug development

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

Call for a Senate Inquiry into the pharmacy industry in Australia

Nonprescription medications to treat upper respiratory infections could save $4.75 billion a year

New Drug Application for Velac accepted for filing by the FDA

Arizona will receive 22,500 additional doses of flu vaccine

Scientists are testing the effectiveness of a new type of flu vaccine

Agreement reached on new community pharmacy contract

The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK

New oral vaccine treatment is effective in reducing Alzheimer's disease pathology

Fatbuster drug targets obesity

Call for disclosure of the prices of the most commonly-used prescription drugs over the Internet

Following the withdrawal of Vioxx, the European Medicines Agency has been asked to review of COX-2 inhibitor medicines

Infectious diseases physicians call for financial incentives for industry

Rosiglitazone helps boost the effectiveness of a treatment for opening clogged arteries

Boehringer Ingelheim - New Drug Application (NDA) for tipranavir

MedImmune bumps up production of FluMist vaccine

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News